Phreesia, Inc.
0A23.L
London Stock Exchange28.50
USD
-0.57
- -
Phreesia, Inc.
0A23.L
(London Stock Exchange)
Recent
price
28.50
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Phreesia, Inc. is a healthcare technology company that provides a comprehensive software-as-a-service (SaaS) platform designed to automate and manage patient intake and engagement processes for healthcare organizations. Its core products include patient registration, scheduling, payments, clinical support, patient surveys, digital forms management, referrals, and analytics solutions, all aimed at improving operational efficiency, patient activation, and care delivery. Phreesia serves healthcare providers, life sciences companies, payers, and other healthcare organizations primarily in the United States and Canada. Founded in 2005 and headquartered in Wilmington, Delaware, Phreesia has developed a broad national footprint, facilitating over 170 million patient visits annually as of 2025. Recent major developments include the acquisition of AccessOne, an electronic forms management and automation provider, announced in late 2025 for $160 million, expected to add approximately $35 million in annual revenue and enhance Phreesia's payment solutions suite. Other key acquisitions include QueueDr (now Appointment Accelerator) for schedule management and Insignia Health, licensor of the Patient Activation Measure. In 2025, Phreesia also launched VoiceAI, a conversational AI solution to optimize call management in healthcare. Furthermore, the company formed a 5-year strategic collaboration with Sesame Workshop to improve child health outcomes through educational initiatives. Phreesia continues to grow its services, including solutions for registration, scheduling, payments, clinical intake, social needs assessment, and patient outreach, to drive efficiencies and enhance patient and staff experiences in healthcare operations. Phreesia's business strategy focuses on secure, reliable, and customizable digital patient intake and workflow automation solutions that enable healthcare providers to collect comprehensive medical and social information before visits, thus improving the quality of care and operational financial performance. The company is publicly traded on the New York Stock Exchange (NYSE: PHR) and maintains a leadership position in patient intake management with a growing client base exceeding 4,000 healthcare service clients across North America. Under the leadership of co-founders Chaim Indig (CEO) and Evan Roberts (President), Phreesia leverages its technology platform to address evolving healthcare delivery needs with continuous product innovation and strategic expansions.